Oral Administration of Histone Deacetylase Inhibitor MS-275 Ameliorates Neuroinflammation and Cerebral Amyloidosis and Improves Behavior in a Mouse Model

Zhang, Zhi-Yuan; Schluesener, Hermann J.

dc.contributor.author	Zhang, Ziyuan
dc.contributor.author	Schlüsener, Hermann
dc.date.accessioned	2013-12-17T08:30:51Z
dc.date.available	2013-12-17T08:30:51Z
dc.date.issued	2013
dc.identifier.issn	0022-3069
dc.identifier.uri	http://hdl.handle.net/10900/39853
dc.language.iso	en	en
dc.publisher	Lippincott Williams & Wilkins	de_DE
dc.relation.uri	http://dx.doi.org/10.1097/NEN.0b013e318283114a	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Oral Administration of Histone Deacetylase Inhibitor MS-275 Ameliorates Neuroinflammation and Cerebral Amyloidosis and Improves Behavior in a Mouse Model	de_DE
dc.type	Article	de_DE
utue.quellen.id	20130911224530_01632	de_DE
utue.publikation.seiten	178-185	de_DE
utue.personen.roh	Zhang, Zhi-Yuan
utue.personen.roh	Schluesener, Hermann J.
dcterms.isPartOf.ZSTitelID	Journal of Neuropathology and Experimental Neurology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	72	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE